Valion Bio, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Valion Bio, Inc. (VBIO) reported Increase (Decrease) in Prepaid Expense and Other Assets of $178.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- Valion Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$163.00K, a 283.15% decline year-over-year.
- Valion Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $341.00K, a 1320.83% increase year-over-year.
- Valion Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$96.00K, a 740.00% decline year-over-year.
- Valion Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$95.00K, a 306.52% decline year-over-year.
- Valion Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$78.00K.
- Valion Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$78.00K, a 184.78% decline from fiscal 2023.
- Valion Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $92.00K.
- Valion Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$558.00K, a 178.93% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 1 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $178.00K 10-Q · filed 2026-08-14 | $82.00K derived: sum of 3 quarters · filed 2026-08-14 | -$13.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $341.00K 10-Q · filed 2026-05-14 | $245.00K derived: sum of 2 quarters · filed 2026-05-14 | $150.00K derived: sum of 3 quarters · filed 2026-05-14 | $239.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$191.00K derived: sum of 2 quarters · filed 2026-03-30 | -$102.00K derived: sum of 3 quarters · filed 2026-08-14 | -$78.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | -$95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$6.00K derived: sum of 2 quarters · filed 2026-08-14 | $18.00K 10-Q · filed 2025-11-14 | $33.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $113.00K 10-Q · filed 2026-08-14 | $128.00K derived: sum of 3 quarters · filed 2026-08-14 | $174.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $24.00K 10-Q · filed 2026-05-14 | $39.00K derived: sum of 2 quarters · filed 2026-05-14 | $85.00K derived: sum of 3 quarters · filed 2026-05-14 | $23.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $61.00K derived: sum of 2 quarters · filed 2026-03-30 | -$1.00K derived: sum of 3 quarters · filed 2026-03-30 | -$78.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$16.00K derived: sum of 2 quarters · filed 2025-11-14 | -$93.00K 10-Q · filed 2025-11-14 | $7.00K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$139.00K 10-Q · filed 2025-08-14 | -$39.00K derived: sum of 3 quarters · filed 2025-08-14 | -$87.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$77.00K 10-Q · filed 2025-05-15 | $23.00K derived: sum of 2 quarters · filed 2025-05-15 | -$25.00K derived: sum of 3 quarters · filed 2025-05-15 | -$44.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $52.00K derived: sum of 2 quarters · filed 2025-03-21 | $33.00K derived: sum of 3 quarters · filed 2025-03-21 | $92.00K 10-K · filed 2025-03-21 | |
| 2023-09-30 | -$48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$67.00K derived: sum of 2 quarters · filed 2024-11-14 | -$8.00K 10-Q · filed 2024-11-14 | -$104.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $40.00K 10-Q · filed 2024-08-14 | -$56.00K derived: sum of 3 quarters · filed 2024-08-14 | -$123.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $59.00K 10-Q · filed 2024-05-15 | -$37.00K derived: sum of 2 quarters · filed 2024-05-15 | -$104.00K derived: sum of 3 quarters · filed 2024-05-15 | -$324.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$163.00K derived: sum of 2 quarters · filed 2024-03-25 | -$383.00K derived: sum of 3 quarters · filed 2024-03-25 | -$558.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | -$67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$287.00K derived: sum of 2 quarters · filed 2023-11-14 | -$462.00K 10-Q · filed 2023-11-14 | $275.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$220.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$395.00K 10-Q · filed 2023-08-14 | $342.00K derived: sum of 3 quarters · filed 2023-08-14 | $374.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$175.00K 10-Q · filed 2023-05-15 | $562.00K derived: sum of 2 quarters · filed 2023-05-15 | $594.00K derived: sum of 3 quarters · filed 2023-05-15 | $470.00K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2022-01-31 | -$175.00K 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | $737.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $769.00K derived: sum of 2 quarters · filed 2023-03-31 | $645.00K derived: sum of 3 quarters · filed 2023-03-31 | $707.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$92.00K derived: sum of 2 quarters · filed 2022-11-14 | -$30.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$62.00K 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $62.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |